It is critical to discover the mechanisms of normal cell cycle regulation if we are to fully understand what goes awry in cancer cells. The normal eukaryotic cell tightly regulates the activity of origins of DNA replication so that the genome is duplicated exactly once per cell cycle. Over the last ten years much has been learned concerning the cell cycle regulation of origin activity. It is now clear that the proteins and cell cycle mechanisms that control origin activity are largely conserved from yeast to humans. Despite this conservation, the composition of origins of DNA replication in higher eukaryotes remains ill defined. A DNA consensus for predicting origins has yet to emerge, and it is of some debate whether primary DNA sequence determines where replication initiates. In this review we outline what is known about origin structure and the mechanism of once per cell cycle DNA replication with an emphasis on recent advances in mammalian cells. We discuss the possible relevance of these regulatory pathways for cancer biology and therapy.
The complete duplication of chromosomes during S phase is required for their proper segregation in mitosis, and ensures that each daughter cell receives a full genome complement. To accomplish this important and large task in a short time, the eukaryotic cell begins DNA replication from numerous origins. Cell cycle checkpoints exist that restrain mitosis if DNA replication is not complete. To avoid genomic instability, however, it is also important that each genomic region is replicated no more than once per cell cycle. Below we concisely review the current model of how the cell regulates origins of DNA replication so that the genome is duplicated exactly once per cell cycle. We discuss the progress and challenges ahead for understanding this process in mammalian cells and its possible relevance to cancer. For in depth discussions of various topics concerning the cell cycle regulation of DNA replication, the interested reader is referred to several excellent recent reviews. [1] [2] [3] It has been more than 30 years since the mammalian cell fusion studies of Rao and Johnson showed that cells in different phases of the cell cycle have different competencies for replicating their genome. 4 When fused with an S phase cell, a G1 nucleus will begin to synthesize its DNA whereas a G2 nucleus will not. We now know that the diffusible factors in S phase cells that induce DNA replication are Cyclin Dependent Kinase 2 (CDK2) with its associated activating cyclin subunits, Cyclin E or Cyclin A (see Table 1 ). 5 The absence of DNA replication in the G2 nucleus, however, suggested the existence of a cell cycle regulation that blocks re-replication once cells have passed through S phase.
Over the last ten years it has become clear that the essential aspect of once per cell cycle DNA replication is that it occurs in two steps. Proteins bind to origins in G1, followed by activation of those proteins to initiate replication in S phase. Upon initiation, these proteins leave origin DNA. Mechanisms that inhibit rebinding of these proteins in S, G2, and M ensure that origins are competent to initiate only once per cell cycle, explaining why an S phase nucleus cannot stimulate a G2 nucleus to re-replicate.
PREPARING FOR S PHASE: BUILDING THE PRE-RC
The first step in DNA replication is the building of a pre-Replicative Complex of proteins (pre-RC) onto origins in early G1. Much of what we know about the proteins of the pre-RC was initially learned through studies in the budding yeast Saccharomyces cerevisiae. 3, 6 It is now clear, however, that these proteins are conserved among all eukaryotes, including humans. 1 Assembly of the pre-RC in G1 occurs stepwise. First, the six subunit Origin Recognition Complex (ORC) binds to origin DNA (Figure 1 ). In yeast, ORC proteins remain bound to the origin throughout the cell cycle. 7 Next, cell division cycle protein 6 (CDC6) associates with the ORC, and acts to load the Mini-Chromosome Maintenance (MCM) proteins onto the pre-RC. 8, 9 The MCM proteins (2-7) form a six-subunit heteromeric complex which is thought to be the replicative helicase. 10, 11 Recently it was shown that another protein, CDT1, also associates with ORC and is required to load the MCM complex onto chromatin. 12, 13 Homologues of CDT1 have now been found in a wide range of eukaryotes, including humans. 14, 15 Once the MCMs are loaded onto chromatin in G1, the pre-RC is complete and origins are considered to be "licensed" for replication. 16 In fact, if ORC and CDC6 proteins are extracted from Xenopus nuclei in vitro, MCMs remain bound to chromatin and nuclei remain competent to initiate replication. 17 
INITIATION OF DNA REPLICATION
S phase begins with the activation of the pre-RC and the initiation of DNA replication. This occurs due to a rise in CDK activity late in G1, and requires another kinase, CDC7, with its activating subunit DBF4. 18, 19 Phosphorylation of MCM proteins by CDC7 is required for activation of the pre-RC. 20 In S. cerevisiae and the fission yeast, S. pombe, a single CDK kinase is activated by different B type cyclins. 6, 21 In higher eukaryotes, the S phase CDK activity is contributed by Cyclin E/CDK2 (CycE/CDK2) and Cyclin A/CDK2 (CycA/CDK2) complexes. CycE/CDK2 stimulates S phase in part by phosphorylation of the retinoblastoma protein (RB). 22 This overcomes the inhibition of RB on the E2F/DP transcription factors, resulting in production of proteins required for S phase. Evidence also suggests that CycE/CDK2 and CycA/CDK2 phosphorylate other targets, including subunits of the pre-RC. 23 In the yeasts S. cerevisiae and S. pombe, these targets include CDC6 and subunits of the ORC and MCM complex. With CDK activation, two proteins associate with the pre-RC: CDC45 and SLD3. 24, 25 These proteins associate with MCMs and are required for loading of the single-stranded DNA binding protein, RPA, and DNA polymerase-alpha:DNA primase, which begins DNA synthesis. 26, 27 In higher eukaryotes phosphorylation of the pre-RC subunits and initiation is dependent on CDKs and CDC7. 28, 29 However, the precise biochemical mechanism by which phosphorylation stimulates initiation remains unclear.
THE BLOCK TO RE-REPLICATION
To avoid unbalanced replication of the genome, it is important that origins initiate replication only once per cell cycle (Figure 2 ). After initiation, CDC6, CDT1 and MCMs dissociate from origin DNA. 2 The block to re-initiation is accomplished by inhibiting reassociation of these proteins with origin DNA in S, G2, and M. Although CDKs stimulate initiation by phosphorylating subunits of the pre-RC, this also leads to dissolution of the complex, and inhibits rebinding to origins. 30 In S. cerevisiae, phosphorylation leads to degradation of CDC6 (CDC18 in S. pombe) by ubiquitin-mediated proteolysis, and the nuclear export of MCM proteins. 31, 32 In vertebrate cells, this regulation is similar but modified. Phosphorylation of CDC6 by CycA/CDK2 leads to its nuclear export, and phosphorylated MCMs remain in the nucleus but dissociated from chromatin. 1, 33, 34 Although ORC remains bound to origins in S. cerevisiae, its phosphorylation appears also to inhibit pre-RC reassembly. 35 In higher eukaryotes, certain subunits of the ORC become destabilized from the complex after initiation, providing another possible mechanism by which re-replication is blocked. 28 A recent report elegantly demonstrated that the blocks to pre-RC assembly and reinitiation are multiply redundant, emphasizing the importance of this inhibition to the cell. Nguyen et al, showed that overcoming the CDK inhibition on ORC, CDC6, and MCMs, singly or pairwise, was insufficient to induce re-replication in S. cerevisiae. 35 It was only when all three blocks were overcome that the cell re-replicated its DNA in G2. Similarly, in higher eukaryotes, mutation of the CDK2 phosphorylation sites on CDC6 results in its nuclear retention, but this is insufficient to stimulate re-replication. 36, 37 Thus it appears that the cell has evolved multiply redundant mechanisms to avoid unbalanced replication and genomic catastrophe.
This redundancy is further emphasized by the finding in vertebrate cells that another mechanism besides CDK phosphorylation also inhibits pre-RC assembly. This mechanism is mediated by the Geminin protein. Addition of excess Geminin to the Xenopus in vitro replication system blocks DNA replication and chromatin association of MCMs. 38 Recently it was shown that human Geminin protein inhibits pre-RC assembly in these in vitro extracts by binding CDT1 and blocking its ability to load the MCM complex. 3, 14, 39 Because Geminin is abundant in S, G2 and M, it may be an important guardian of genomic stability in human cells. It is only after Cyclins and Geminin become targeted for degradation at the end of mitosis that a cell can re-assemble the pre-RC in preparation for another S phase. Why a cell would need Geminin, however, in addition to the other multiply redundant blocks to re-replication, remains an important question. 
WHAT IS AN ORIGIN IN MULTICELLULAR EUKARYOTES?
In S. cerevisiae, what comprises an origin of DNA replication is relatively well defined. These origins were originally identified by testing segments of DNA for their ability to confer replicative competence to an extrachromosomal episome, and are called autonomously replicating sequences (ARSs). 40 Some were subsequently shown to be origins of DNA replication in their natural position on the chromosome. Budding yeast origins are relatively small in size (100-150 bp) and contain multiple functional subsequences. The most highly conserved is the ARS Consensus Sequence (ACS), which is part of the binding site for the ORC. Another subsequence constitutes what is thought to be the DNA unwinding element (DUE), the putative site where DNA unwinding begins. Some origins also contain a subsequence that binds the transcription factor Abf1, which stimulates replication initiation. A recently developed high resolution mapping technique, Replication Initiation Point mapping (RIP), has shown that bidirectional replication begins at a site flanking the ORC binding site in ARS1. 41 Over 30 years ago, microscopic visualization of radioactive nucleotide incorporation indicated that replication begins on mammalian chromosomes from bidirectional origins of DNA replication. 42 Origins of DNA replication in multicellular eukaryotes (the metazoa), however, remain ill defined relative to those in budding yeast. 28 A DNA consensus for predicting origins or where the pre-RC will bind has yet to emerge. An ARS assay equivalent to that in yeast has not aided identification of origins in higher eukaryotes. The size of the DNA fragment appears to be more important than the DNA sequence for determining replication competence in frog extracts or cells in culture. Consequently, a number of biochemical methods have been used to map the physical site at which DNA synthesis initiates. Some of these methods map origins by identifying the sequences that are replicated first in S phase, or rely on the switch from leading and lagging strand replication on the two sides of the initiation site by analyzing Okazaki fragments. 43 Start points for replication have also been mapped by two-dimensional agarose gels which exploit the different migration patterns of replication intermediates. 28 The current view is that metazoan origins contain preferred sites of initiation, used in most cell cycles, surrounded by a region that contains less frequently used sites. If the preferred site of initiation is compromised, replication can initiate at these secondary sites. Application of the high resolution RIP mapping technique to the origin at the human lamin B locus confirms that bi-directional replication initiates at a precise and conserved site in most cell cycles. 44 A small number of origins have also been subjected to genetic mapping in an effort to identify the sequences essential for activity. 40 In these assays, origin activity is measured after insertion of the putative origin into an ectopic chromosomal site or deletion of sequences at the natural locus. The general theme that has emerged is that origins in metazoa are larger and more complex than those in budding yeast. Even in the yeast S. pombe, functional origins have been shown to bẽ 1 kb, with multiple stretches of AT-rich sequences that are required for function, but no easily identifiable consensus sequence. 45 In mammalian cells, sequences as far as 50 kb away can influence the frequency of initiation of an origin. The stable association of ORC with bulk chromatin in G1 correlates with the establishment of origin identity in mammalian cells. 46 It remains a mystery, however, how the pre-RC is stably associated with only some regions on metazoan chromosomes. It appears that ORC in higher eukaryotes has a relaxed binding specificity, and therefore biochemical methods that rely on mapping the interaction sites of ORC with DNA have not been informative for identifying origins. Evidence suggests that chromatin structure, and not just DNA sequence, may be a large factor in determining where the pre-RC will bind and replication will initiate. 47 The number and identity of origins can change during development and this correlates with changes in chromosome structure. When moved to ectopic genomic positions, the chromosomal context of an origin can greatly affect its ability to fire. However, genetic GENOME DUPLICATION 10 Cancer Biology & Therapy 2002; Vol. 1 Issue 1 Figure 1 . The pre-Replicative Complex (pre-RC) and S phase kinases. In G1, CDT1 and CDC6 proteins associate with ORC at origins and load the MCM complex. Later, this pre-RC is activated to initiate DNA replication through the action of DBF4/CDC7 kinase and the CDK complexes CycA/CDK2 and CycE/CDK2. See text and Table 1 for details and abbreviations.
analyses have also shown that the activity of certain metazoan origins does depend on some specific DNA subsequences, believed to direct the assembly of the pre-RC. 28 The ability to insert wild-type or mutant versions of a mammalian origin into the same genomic site by using site specific recombination systems is especially promising for identifying sequences that are important for origin activity. 48 
DEVELOPMENTAL AMPLIFICATION: A MODEL SYSTEM FOR ORIGIN IDENTITY AND REGULATION
Although progress is being made in human cells, model organisms continue to contribute to the investigation of origin composition and regulation. Two of these model organisms are the fruit fly Drosophila melanogaster and the fungus fly Sciara coprophila. In these two flies, genes become amplified through re-replication at specific times in development. In Drosophila, two loci of eggshell (chorion) protein genes are amplified in the ovary to support rapid synthesis of the eggshell. 49 Sequences from these loci can direct amplification in the fly ovary when transformed into ectopic genomic sites. This has facilitated the genetic mapping of subregions at the chorion locus that are essential for amplification. Two of these subregions were shown to bind to fly ORC in vitro and in vivo, the first demonstration of specific ORC binding in metazoa. 50 The genetics of the fruit fly has also contributed to our understanding of origin regulation. Genes that are required for the activity of these origins have a distinct mutant phenotype; females lay eggs with thin eggshells due to a defect in amplification. The molecular identification of these genes over the last few years has revealed that amplification origins are regulated by proteins known to be critical for G1/S phase progression. 51 These include proteins of the pre-RC and the S phase kinases CycE/CDK2 and CDC7/DBF4. This suggests that a continued search for mutations that cause thin eggshells, combined with the molecular and genetic tools available in Drosophila, will provide insight into origin regulation.
In Sciara, amplification increases copy number of genes in the larva during metamorphosis. This robust developmentally-programmed re-replication has facilitated molecular mapping of the origin at the Sciara II/9A locus. A recent elegant report of ORC binding and RIP mapping at the II/9A locus indicates that replication initiates adjacent to the ORC binding site as it does in S. cerevisiae. 52 This encourages the idea that although the regulation is likely more complex in metazoa, the basic mechanism for pre-RC activation and replication initiation is conserved with yeast. To date, the chorion locus of Drosophila and the II/9A locus of Sciara are the two origins in metazoa for which ORC binding has been shown. Given that these loci are developmentally amplified, however, it is still an open question as to how similar these origins are to those that control chromosome duplication during other cell cycles. Nonetheless, these two systems are among the most promising for clarifying the hazy picture of origin composition and pre-RC regulation in metazoa. Figure 2 . The control of once per cell cycle DNA replication. The pre-RC, comprised of ORC, CDT1, CDC6 and the MCM complex, forms on origins in early G1 when CDK activity is low. In S phase, CDC7 and CDKs stimulate the pre-RC to initiate DNA replication, likely by phosphorylating multiple subunits (arrows). Upon initiation, CDC6 and CDT1 dissociate from chromatin and the MCM complex is thought to travel with the replication forks and act as the replicative helicase. During S, G2, and M phases, the pre-RC can not reform due to the persistence of CDK activity and the negative inhibitor Geminin. The pre-RC can reassemble when cyclins and Geminin are degraded upon completion of mitosis. This restricts origin firing to once per cell division.
WHAT IS THE ROLE OF DNA REPLICATION CONTROL IN THE CANCER CELL?
The decision to enter a round of cell division begins in G1 with the commitment to enter S phase and activate origins of DNA replication. Mutation or amplification of genes required for normal G1/S phase progression are frequent causes of cancer. Thus it is important to ask what role proteins associated with origins play in the cancer cell. In this regard it is important to note that, unlike yeast and flies, in mammalian cells ORC1 and ORC6 are less tightly associated with the other ORC subunits, and it has been problematic to isolate a holocomplex from cancer cell lines. [53] [54] [55] [56] [57] It is therefore an interesting possibility that formation of the ORC holocomplex plays a role in the cell cycle regulation of origin firing in normal and cancer cells. The human ORC5L gene resides in a chromosomal region that is deleted in a subset of uterine leiomyomas, adult myeloid leukemias, and myelodysplastic syndrome. 58 It is not clear that ORC5L is relevant to disease, however, because DNA sequencing and expression analysis from myeloid leukemia patients that are heterozygous for the locus did not find evidence for point mutation or imprinting of the undeleted allele of the ORC5L gene. 59 To date there is no evidence for mutation or amplification of the pre-RC proteins themselves in human cancers. One explanation for this could be that these proteins act as large heteromeric complexes that must be activated by CDKs. Upregulation of CDK activity or mutation of the RB negative regulator are frequent in cancer cells. Recent reports suggest that RB protein is localized to sites of DNA replication in vertebrate cells. 60 In Drosophila, an RB related protein associates with ORC at chorion amplification origins and negatively regulates DNA replication. 61 This suggests that hyperactivation of the pre-RC may be a direct target of aberrant G1/S phase progression in cancer cells with mutated RB or upregulated CDKs.
In addition to cellular CDKs, those encoded by viruses can subvert normal cell cycle regulation. Kaposi's sarcoma-associated herpes virus (KSHV) and herpesvirus saimiri, associated with T cell lymphomas in primates, encode a cyclin D homolog that complexes with cellular CDK6 and targets a number of cell cycle regulatory molecules, such as RB, thereby stimulating cell proliferation. 62 It was recently shown that viral CycD/CDK6 phosphorylates pre-RC subunits ORC1 and CDC6, and can promote the initiation of DNA replication in vitro. 63 Thus it appears that the multi-pronged attack of these cancerassociated viruses on the cell cycle includes the proteins bound to origins leading directly to the initiation of DNA replication.
Abundant expression of the pre-RC and associated proteins is essential to support the proliferation of the cancer cell. Indeed, quiescent G0 cells that have withdrawn from the cell cycle are unable to form functional pre-RCs, possibly as a redundant mechanism to ensure cell cycle arrest. 64 When G0 cells re-enter the cell cycle in neoplastic disease states, pre-RC components and other DNA replication genes are abundantly expressed. In fact, antibodies against MCM5 and CDC6 proteins have proven to be sensitive diagnostic tools for Papanicolaou (Pap) smear tests. 65 Therefore, although mutation of these proteins may not be sufficient for neoplastic disease, restraining their activity could be one target for therapeutics. One potential approach would be to inhibit the essential ATP binding and hydrolysis functions of several of the pre-RC subunits through rational drug design. Another potential approach could be to exploit the Geminin protein as a natural inhibitor of pre-RC formation. 66 The recent finding that cellular pre-RC components are required for Epstein Barr virus replication suggests that such an approach may be most efficacious in those cancers to which Herpes viruses may contribute. [66] [67] [68] Amplification of genes that promote cell division contributes to the proliferation of the cancer cell. 69 An important, unanswered question is to what extent re-replication at specific origins may be part of the mechanism for amplification. Amplification in cancer cells involves genetic rearrangement into minute chromosomes or homogeneously staining regions that contain tandem copies of the amplified gene. This is different from the programmed developmental amplification in Drosophila and Sciara, which occurs by re-replication without genetic rearrangement. It is possible, however, that early events of genomic instability in the cancer cell could entail unregulated origin firing, providing substrates for genetic recombination and further amplification. Although this suggestion is highly speculative, it will be interesting to see if further mapping of human origins of DNA replication places them near loci that are known to be amplified in cancer. One notable correlation is at the myc locus, which is one of the well defined human origins and whose amplification contributes to cancer. Other genes whose amplification contributes to cancer, such as Cyclin D, have not had origins mapped near them. 70 Clearly, further mapping of origins of DNA replication in human cells is needed before the relationship between origin regulation and genomic instability can be fully evaluated.
CONCLUSION
The last ten years have witnessed great advances in discovering how the cell controls the duplication of chromosomes. The challenge ahead is to define what constitutes an origin of DNA replication in higher eukaryotes, and to discover the full repertoire of cell cycle regulation that stimulates replication only once per cell cycle. A central remaining question is what dictates the binding of the pre-RC to specific sites on chromosomes when origins are licensed for DNA replication. To define the biochemical mechanism of initiation and re-replication inhibition, it is important to identify all the targets of Cyclin Dependent Kinases at origins of DNA replication. Moreover, given that the block to re-replication by CDKs is multiply redundant, why do cells encode the additional negative regulator Geminin? Is this protein essential to regulate origin licensing in all cell cycles or as part of a cell cycle checkpoint? It is important for us to answer these and other questions regarding the cell cycle regulation of DNA replication if we are to fully understand the cancer cell.
